(Stock image generated with AI.)

Canada’s main stock index retreated on Monday, despite gains in precious metals. Recent domestic inflation figures had minimal impact on expectations for the Bank of Canada’s monetary policy trajectory.

Following a less-than-stellar performance on Wall Street last week, US markets moved lower as investors shifted out of technology stocks and into sectors with more attractive valuations. Market participants are also preparing for a series of key US economic data releases later this week.

TSX31,483.44-43.95TSX
TSXV944.87-9.74TSXV
CSE180.36-26.35CSE
DJIA48,416.56-41.49DJIA
NASDAQ23,057.41-137.76NASDAQ
S&P 5006,816.51-10.90S&P 500

The Canadian dollar traded remained at 72.61 cents US.

US crude futures traded $0.77 lower at US$56.67 a barrel, and the Brent contract lost $0.72 to US$60.40 a barrel.

The price of gold was up US$3.39 to US$4,303.79.

In world markets, the Nikkei was down 668.44 points to ¥50,168.11, the Hang Seng was down 347.91 points to HK$25,628.88, the FTSE was up 102.28 points to ₤9,751.31, and the DAX was up 43.42 points to €24,229.91.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.


More From The Market Online

@ the Bell: No joke! Markets rise as investors await key Middle East update

Canada’s main stock index moved higher on Wednesday as global markets climbed, encouraged by comments from...
The Market Online Video

Exploring a region with deep gold history and modern discovery potential

Hello, I’m Ricki Lee, and this is The Capital Compass. Today we’re heading to South America...
The Market Online Video

Consumer packaged goods company acquires beverage manufacturing facility

In this Capital Compass episode, Cizzle Brands discusses acquiring a beverage manufacturing facility, adding vertical integration, guaranteed customers, and a clearer path to profitability.
The Market Online Video

Developing a neurosciences platform with potential applications across several indications

In this Capital Compass episode, Marvel Biosciences outlines progress on MB-204, its neuroscience platform targeting autism, Rett syndrome, Fragile X, and Alzheimer’s disease ahead…